Düsseldorf, June 24, 2025 – Telemedicine provider dermanostic has successfully closed a €4 million Pre-Series A funding round. The round was led by Dieter von Holtzbrinck Ventures (DvH Ventures), with participation from existing investors in the tech and healthcare sectors as well as a network of experienced entrepreneurs.

Scaling in Germany and Europe

dermanostic is one of Germany’s leading digital dermatology platforms, aiming to make dermatological care more efficient and accessible. Patients can submit photos and a short medical questionnaire via the app and receive a specialist diagnosis within hours—prescriptions included when needed. Backed by a team of over 20 board-certified dermatologists, dermanostic ensures high medical standards through an asynchronous treatment model.

With the new funding, dermanostic plans to further expand in the DACH region and scale its technology across Europe, maintaining compliance with strict medical regulations such as MDR Class IIa certification. Strategic partnerships with health insurers are part of the company’s roadmap to set new standards in digital skin care.

Lead investor DvH Ventures, a key early-stage investor since 2014, supports dermanostic with both capital and a media-for-equity package, granting access to targeted audiences. DvH Ventures focuses on tech-driven startups and recognized the potential of teledermatology early on.

About dermanostic
dermanostic offers dermatological diagnosis and treatment within 24 hours via app—requiring only three skin photos and a brief questionnaire. Certified under MDR Class IIa and TÜV-approved for data privacy, the company is redefining access to skin care with a team of over 50 employees.

Media Contact
Laura Siebertz
Email: presse@dermanostic.com
Phone: +49 211 9425 5864
https://dermanostic.com